Tibet Cheezheng Tibetan Medicine Co Ltd Working Capital to Net Assets Ratio
Tibet Cheezheng Tibetan Medicine Co Ltd working capital to net assets ratio. Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Working Capital to Net Assets ratio of 54.3% as of March 2026. Working capital of CN¥2.76 Billion (current assets of CN¥4.07 Billion minus current liabilities of CN¥1.31 Billion) is measured against net assets of CN¥5.09 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Working capital to net assets ratio of Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2025. This chart shows how Tibet Cheezheng Tibetan Medicine Co Ltd's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 54.3%, reflecting working capital of CN¥2.76 Billion against net assets of CN¥5.09 Billion CNY. Explore Tibet Cheezheng Tibetan Medicine Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Tibet Cheezheng Tibetan Medicine Co Ltd Working Capital to Net Assets Ratio by Year (2006–2025)
Tibet Cheezheng Tibetan Medicine Co Ltd working capital to net assets ratio by year from 2006 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Tibet Cheezheng Tibetan Medicine Co Ltd (002287) total assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 52.6% | CN¥2.63 Billion | CN¥5.00 Billion | CN¥4.31 Billion | CN¥1.68 Billion | ▼ -7.9 pp |
| 2024 | 60.5% | CN¥2.49 Billion | CN¥4.11 Billion | CN¥4.15 Billion | CN¥1.66 Billion | ▲ +8.8 pp |
| 2023 | 51.7% | CN¥1.95 Billion | CN¥3.77 Billion | CN¥3.19 Billion | CN¥1.25 Billion | ▼ -2.4 pp |
| 2022 | 54.1% | CN¥1.83 Billion | CN¥3.39 Billion | CN¥3.19 Billion | CN¥1.36 Billion | ▲ +3.5 pp |
| 2021 | 50.6% | CN¥1.63 Billion | CN¥3.22 Billion | CN¥2.94 Billion | CN¥1.31 Billion | ▼ -33.3 pp |
| 2020 | 83.8% | CN¥2.21 Billion | CN¥2.63 Billion | CN¥2.97 Billion | CN¥761.96 Million | ▲ +18.3 pp |
| 2019 | 65.5% | CN¥1.48 Billion | CN¥2.26 Billion | CN¥2.14 Billion | CN¥654.13 Million | ▲ +2.6 pp |
| 2018 | 62.9% | CN¥1.29 Billion | CN¥2.05 Billion | CN¥1.49 Billion | CN¥202.28 Million | ▼ -1.4 pp |
| 2017 | 64.3% | CN¥1.22 Billion | CN¥1.89 Billion | CN¥1.56 Billion | CN¥340.18 Million | ▼ -0.1 pp |
| 2016 | 64.4% | CN¥1.13 Billion | CN¥1.75 Billion | CN¥1.39 Billion | CN¥263.02 Million | ▲ +1.3 pp |
| 2015 | 63.1% | CN¥1.04 Billion | CN¥1.65 Billion | CN¥1.39 Billion | CN¥347.59 Million | ▼ -13.1 pp |
| 2014 | 76.2% | CN¥1.18 Billion | CN¥1.55 Billion | CN¥1.35 Billion | CN¥173.53 Million | ▼ -1.4 pp |
| 2013 | 77.6% | CN¥1.12 Billion | CN¥1.45 Billion | CN¥1.16 Billion | CN¥39.23 Million | ▼ -1.9 pp |
| 2012 | 79.5% | CN¥1.07 Billion | CN¥1.35 Billion | CN¥1.14 Billion | CN¥60.32 Million | ▲ +0.0 pp |
| 2011 | 79.5% | CN¥1.02 Billion | CN¥1.28 Billion | CN¥1.09 Billion | CN¥71.20 Million | ▼ -8.6 pp |
| 2010 | 88.1% | CN¥1.07 Billion | CN¥1.21 Billion | CN¥1.17 Billion | CN¥102.25 Million | ▼ -2.5 pp |
| 2009 | 90.6% | CN¥1.04 Billion | CN¥1.14 Billion | CN¥1.18 Billion | CN¥140.68 Million | ▲ +12.9 pp |
| 2008 | 77.7% | CN¥413.69 Million | CN¥532.28 Million | CN¥504.84 Million | CN¥91.14 Million | ▲ +4.3 pp |
| 2007 | 73.4% | CN¥290.82 Million | CN¥396.33 Million | CN¥399.24 Million | CN¥108.42 Million | ▼ -4.4 pp |
| 2006 | 77.8% | CN¥355.27 Million | CN¥456.61 Million | CN¥487.35 Million | CN¥132.08 Million | — |